rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jose Carmona

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, ADC Therapeutics SA; Chief Financial Officer, Rubius Therapeutics; Chief Financial Officer, Radius Health.

Every Form 4 they filed

In numbers

Trades disclosed
20
Buys
1
Sells
1
Bought
$98K
Sold
$23K
Companies
3
Companies where not an officer
0
First trade
15 May 2017
Last trade
30 Jun 2026
Last filed
2 Jul 2026

Companies traded

Where they are an officer
ADCT ADC Therapeutics SAOfficer · Biotechnology · last 30 Jun 20260 buys · 0 sells
Rubius TherapeuticsOfficer · last 31 Jan 20220 buys · 0 sells
Radius HealthOfficer · last 26 Feb 20201 buy · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Jun 2026filed 2 Jul 2026ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code A—203,700 at $0.00filing
30 Jun 2026filed 2 Jul 2026ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code A—203,700 at $0.00filing
13 Feb 2026filed 18 Feb 2026ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code A$1.1M271,600 at $3.99filing
13 Feb 2026filed 18 Feb 2026ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code F$103K25,880 at $3.99filing
13 Feb 2026filed 18 Feb 2026ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code A$1.1M271,600 at $3.99filing
13 Feb 2026filed 18 Feb 2026ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code F$103K25,880 at $3.99filing
6 Dec 2025filed 9 Dec 2025ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code F$175K53,236 at $3.29filing
13 Feb 2025filed 14 Feb 2025ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code A$386K240,000 at $1.61filing
6 Dec 2024filed 9 Dec 2024ADCT ADC Therapeutics SABiotechnologySEC FORM 4 Code F$151K48,108 at $3.13filing
31 Jan 2022filed 1 Feb 2022Rubius Therapeuticsoption or derivativeSEC FORM 4 Code A—143,750 at $0.00filing
31 Jan 2022filed 1 Feb 2022Rubius Therapeuticsoption or derivativeSEC FORM 4 Code A—34,500 at $0.00filing
30 Nov 2020filed 2 Dec 2020Rubius Therapeuticsoption or derivativeSEC FORM 4 Code A—400,000 at $0.00filing
26 Feb 2020filed 28 Feb 2020Radius HealthSEC FORM 4 Sold$23K1,292 at $17.93filing
20 Feb 2020filed 24 Feb 2020Radius Healthoption or derivativeSEC FORM 4 Code A—45,000 at $0.00filing
20 Feb 2020filed 24 Feb 2020Radius HealthSEC FORM 4 Code A—30,000filing
22 Feb 2019filed 26 Feb 2019Radius Healthoption or derivativeSEC FORM 4 Code A—55,000 at $0.00filing
22 Feb 2019filed 26 Feb 2019Radius HealthSEC FORM 4 Code A—15,000filing
13 Feb 2018filed 15 Feb 2018Radius Healthoption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing
14 Sep 2017filed 15 Sep 2017Radius HealthSEC FORM 4 Bought$98K3,000 at $32.83filing
15 May 2017filed 16 May 2017Radius Healthoption or derivativeSEC FORM 4 Code A—125,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Ameet MallikChief Executive Officer · Chief Executive Officer at ADC Therapeutics SA, filing Form 4 there in the last year
Peter J. GrahamChief Legal Officer · Chief Legal Officer at ADC Therapeutics SA, filing Form 4 there in the last year
Mohamed ZakiChief Medical Officer · Chief Medical Officer at ADC Therapeutics SA, filing Form 4 there in the last year
Victor SandorDirector · Director at ADC Therapeutics SA, filing Form 4 there in the last year
Jean-Pierre BizzariDirector · Director at ADC Therapeutics SA, filing Form 4 there in the last year